High myocardial PD-L1 expression is associated with greater disease severity and a higher risk of major adverse cardiotoxic events in immune checkpoint inhibitor-associated myocarditis.
Does high myocardial PD-L1 expression predict greater disease severity and higher risk of major adverse cardiotoxic events in patients with ICI-associated myocarditis?
Assessment of PD-L1 expression in endomyocardial biopsy specimens may serve as a prognostic marker to identify high-risk patients with ICI-associated myocarditis who may benefit from early intervention.
Absolute Event Rate: 0% vs 0%
High myocardial PD-L1 expression is associated with greater disease severity and a higher risk of major adverse cardiotoxic events in ICI-associated myocarditis. Assessment of PD-L1 expression in endomyocardial biopsy specimens may help identify patients at high risk who may benefit from early intervention and closer monitoring.
Imaoka et al. (Wed,) reported a other. High myocardial PD-L1 expression is associated with greater disease severity and a higher risk of major adverse cardiotoxic events in immune checkpoint inhibitor-associated myocarditis.